Neurodegenerative diseases and disorders represent the largest challenge to the global healthcare system. There are no objective, quantitative tools to measure brain health.
Early Detection
Sub-clinical measurement tools will allow researchers to develop drugs to treat brain diseases much earlier, before symptoms become visible. Researchers believe that slowing down or even reversing the progression of brain diseases is possible with early treatment.
Measurement
Quantitative tools will allow physicians to differentiate among diseases, measure and predict progression over time and differentiate patients, enabling early detection and more precise diagnoses. Managed care providers will be able to measure outcomes and identify best practices.
Monitoring
A passive, non-invasive real-time, continuous monitoring solution which measures progression over time will enable pro-active, predictive and personalized patient management. Patients (and their caregivers) will be able to be more involved in the management of their diseases.
Location: United States, California, San Francisco
Member count: 1-10
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | Plug and P... | plugandpla... |
| - | Curitas Ve... | curitasven... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 27.11.2017 | Internatio... | The group also runs digital he... | - | - | medcitynew... |
| 27.11.2017 | Startupboo... | International accelerator prog... | - | Dave Muoio | mobihealth... |
| - | Internatio... | Startupbootcamp Digital Health... | - | - | medcitynew... |